img

Global Human Bacterial Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Bacterial Vaccine Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Human Bacterial Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Bacterial Vaccine market research.
Key companies engaged in the Human Bacterial Vaccine industry include Merck, Sanofi, GSK, Mitsubishi Tanabe Pharma, Pfizer, Bayer and Emergent BioSolutions, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Human Bacterial Vaccine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human Bacterial Vaccine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Bacterial Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Sanofi
GSK
Mitsubishi Tanabe Pharma
Pfizer
Bayer
Emergent BioSolutions
Segment by Type
Clostridium Tetani
Pertussis
Haemophilus Influenzae
Streptococcus Pneumoniae
Salmonella Typhi
Bacillus Anthracis
Others

Segment by Application


Children
Adults
Elderly
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Human Bacterial Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Bacterial Vaccine Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Clostridium Tetani
1.2.3 Pertussis
1.2.4 Haemophilus Influenzae
1.2.5 Streptococcus Pneumoniae
1.2.6 Salmonella Typhi
1.2.7 Bacillus Anthracis
1.2.8 Others
1.3 Market by Application
1.3.1 Global Human Bacterial Vaccine Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Bacterial Vaccine Market Perspective (2024-2034)
2.2 Human Bacterial Vaccine Growth Trends by Region
2.2.1 Global Human Bacterial Vaccine Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Human Bacterial Vaccine Historic Market Size by Region (2024-2024)
2.2.3 Human Bacterial Vaccine Forecasted Market Size by Region (2024-2034)
2.3 Human Bacterial Vaccine Market Dynamics
2.3.1 Human Bacterial Vaccine Industry Trends
2.3.2 Human Bacterial Vaccine Market Drivers
2.3.3 Human Bacterial Vaccine Market Challenges
2.3.4 Human Bacterial Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Bacterial Vaccine Players by Revenue
3.1.1 Global Top Human Bacterial Vaccine Players by Revenue (2024-2024)
3.1.2 Global Human Bacterial Vaccine Revenue Market Share by Players (2024-2024)
3.2 Global Human Bacterial Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Bacterial Vaccine Revenue
3.4 Global Human Bacterial Vaccine Market Concentration Ratio
3.4.1 Global Human Bacterial Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Bacterial Vaccine Revenue in 2022
3.5 Human Bacterial Vaccine Key Players Head office and Area Served
3.6 Key Players Human Bacterial Vaccine Product Solution and Service
3.7 Date of Enter into Human Bacterial Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Bacterial Vaccine Breakdown Data by Type
4.1 Global Human Bacterial Vaccine Historic Market Size by Type (2024-2024)
4.2 Global Human Bacterial Vaccine Forecasted Market Size by Type (2024-2034)
5 Human Bacterial Vaccine Breakdown Data by Application
5.1 Global Human Bacterial Vaccine Historic Market Size by Application (2024-2024)
5.2 Global Human Bacterial Vaccine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Human Bacterial Vaccine Market Size (2024-2034)
6.2 North America Human Bacterial Vaccine Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Human Bacterial Vaccine Market Size by Country (2024-2024)
6.4 North America Human Bacterial Vaccine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Bacterial Vaccine Market Size (2024-2034)
7.2 Europe Human Bacterial Vaccine Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Human Bacterial Vaccine Market Size by Country (2024-2024)
7.4 Europe Human Bacterial Vaccine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Bacterial Vaccine Market Size (2024-2034)
8.2 Asia-Pacific Human Bacterial Vaccine Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Human Bacterial Vaccine Market Size by Region (2024-2024)
8.4 Asia-Pacific Human Bacterial Vaccine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Bacterial Vaccine Market Size (2024-2034)
9.2 Latin America Human Bacterial Vaccine Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Human Bacterial Vaccine Market Size by Country (2024-2024)
9.4 Latin America Human Bacterial Vaccine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Bacterial Vaccine Market Size (2024-2034)
10.2 Middle East & Africa Human Bacterial Vaccine Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Human Bacterial Vaccine Market Size by Country (2024-2024)
10.4 Middle East & Africa Human Bacterial Vaccine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Human Bacterial Vaccine Introduction
11.1.4 Merck Revenue in Human Bacterial Vaccine Business (2024-2024)
11.1.5 Merck Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Human Bacterial Vaccine Introduction
11.2.4 Sanofi Revenue in Human Bacterial Vaccine Business (2024-2024)
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Human Bacterial Vaccine Introduction
11.3.4 GSK Revenue in Human Bacterial Vaccine Business (2024-2024)
11.3.5 GSK Recent Development
11.4 Mitsubishi Tanabe Pharma
11.4.1 Mitsubishi Tanabe Pharma Company Detail
11.4.2 Mitsubishi Tanabe Pharma Business Overview
11.4.3 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Introduction
11.4.4 Mitsubishi Tanabe Pharma Revenue in Human Bacterial Vaccine Business (2024-2024)
11.4.5 Mitsubishi Tanabe Pharma Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Human Bacterial Vaccine Introduction
11.5.4 Pfizer Revenue in Human Bacterial Vaccine Business (2024-2024)
11.5.5 Pfizer Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Human Bacterial Vaccine Introduction
11.6.4 Bayer Revenue in Human Bacterial Vaccine Business (2024-2024)
11.6.5 Bayer Recent Development
11.7 Emergent BioSolutions
11.7.1 Emergent BioSolutions Company Detail
11.7.2 Emergent BioSolutions Business Overview
11.7.3 Emergent BioSolutions Human Bacterial Vaccine Introduction
11.7.4 Emergent BioSolutions Revenue in Human Bacterial Vaccine Business (2024-2024)
11.7.5 Emergent BioSolutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Bacterial Vaccine Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Clostridium Tetani
Table 3. Key Players of Pertussis
Table 4. Key Players of Haemophilus Influenzae
Table 5. Key Players of Streptococcus Pneumoniae
Table 6. Key Players of Salmonella Typhi
Table 7. Key Players of Bacillus Anthracis
Table 8. Key Players of Others
Table 9. Global Human Bacterial Vaccine Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 10. Global Human Bacterial Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 11. Global Human Bacterial Vaccine Market Size by Region (2024-2024) & (US$ Million)
Table 12. Global Human Bacterial Vaccine Market Share by Region (2024-2024)
Table 13. Global Human Bacterial Vaccine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 14. Global Human Bacterial Vaccine Market Share by Region (2024-2034)
Table 15. Human Bacterial Vaccine Market Trends
Table 16. Human Bacterial Vaccine Market Drivers
Table 17. Human Bacterial Vaccine Market Challenges
Table 18. Human Bacterial Vaccine Market Restraints
Table 19. Global Human Bacterial Vaccine Revenue by Players (2024-2024) & (US$ Million)
Table 20. Global Human Bacterial Vaccine Market Share by Players (2024-2024)
Table 21. Global Top Human Bacterial Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Bacterial Vaccine as of 2022)
Table 22. Ranking of Global Top Human Bacterial Vaccine Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Human Bacterial Vaccine Revenue (CR5 and HHI) & (2024-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Human Bacterial Vaccine Product Solution and Service
Table 26. Date of Enter into Human Bacterial Vaccine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Bacterial Vaccine Market Size by Type (2024-2024) & (US$ Million)
Table 29. Global Human Bacterial Vaccine Revenue Market Share by Type (2024-2024)
Table 30. Global Human Bacterial Vaccine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 31. Global Human Bacterial Vaccine Revenue Market Share by Type (2024-2034)
Table 32. Global Human Bacterial Vaccine Market Size by Application (2024-2024) & (US$ Million)
Table 33. Global Human Bacterial Vaccine Revenue Market Share by Application (2024-2024)
Table 34. Global Human Bacterial Vaccine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 35. Global Human Bacterial Vaccine Revenue Market Share by Application (2024-2034)
Table 36. North America Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 37. North America Human Bacterial Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 38. North America Human Bacterial Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 40. Europe Human Bacterial Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 41. Europe Human Bacterial Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 42. Asia-Pacific Human Bacterial Vaccine Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 43. Asia-Pacific Human Bacterial Vaccine Market Size by Region (2024-2024) & (US$ Million)
Table 44. Asia-Pacific Human Bacterial Vaccine Market Size by Region (2024-2034) & (US$ Million)
Table 45. Latin America Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 46. Latin America Human Bacterial Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 47. Latin America Human Bacterial Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 48. Middle East & Africa Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 49. Middle East & Africa Human Bacterial Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 50. Middle East & Africa Human Bacterial Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck Human Bacterial Vaccine Product
Table 54. Merck Revenue in Human Bacterial Vaccine Business (2024-2024) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Human Bacterial Vaccine Product
Table 59. Sanofi Revenue in Human Bacterial Vaccine Business (2024-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. GSK Company Detail
Table 62. GSK Business Overview
Table 63. GSK Human Bacterial Vaccine Product
Table 64. GSK Revenue in Human Bacterial Vaccine Business (2024-2024) & (US$ Million)
Table 65. GSK Recent Development
Table 66. Mitsubishi Tanabe Pharma Company Detail
Table 67. Mitsubishi Tanabe Pharma Business Overview
Table 68. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product
Table 69. Mitsubishi Tanabe Pharma Revenue in Human Bacterial Vaccine Business (2024-2024) & (US$ Million)
Table 70. Mitsubishi Tanabe Pharma Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Human Bacterial Vaccine Product
Table 74. Pfizer Revenue in Human Bacterial Vaccine Business (2024-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Bayer Company Detail
Table 77. Bayer Business Overview
Table 78. Bayer Human Bacterial Vaccine Product
Table 79. Bayer Revenue in Human Bacterial Vaccine Business (2024-2024) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Emergent BioSolutions Company Detail
Table 82. Emergent BioSolutions Business Overview
Table 83. Emergent BioSolutions Human Bacterial Vaccine Product
Table 84. Emergent BioSolutions Revenue in Human Bacterial Vaccine Business (2024-2024) & (US$ Million)
Table 85. Emergent BioSolutions Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Bacterial Vaccine Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Human Bacterial Vaccine Market Share by Type: 2022 VS 2034
Figure 3. Clostridium Tetani Features
Figure 4. Pertussis Features
Figure 5. Haemophilus Influenzae Features
Figure 6. Streptococcus Pneumoniae Features
Figure 7. Salmonella Typhi Features
Figure 8. Bacillus Anthracis Features
Figure 9. Others Features
Figure 10. Global Human Bacterial Vaccine Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Human Bacterial Vaccine Market Share by Application: 2022 VS 2034
Figure 12. Children Case Studies
Figure 13. Adults Case Studies
Figure 14. Elderly Case Studies
Figure 15. Human Bacterial Vaccine Report Years Considered
Figure 16. Global Human Bacterial Vaccine Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 17. Global Human Bacterial Vaccine Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 18. Global Human Bacterial Vaccine Market Share by Region: 2022 VS 2034
Figure 19. Global Human Bacterial Vaccine Market Share by Players in 2022
Figure 20. Global Top Human Bacterial Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Bacterial Vaccine as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Human Bacterial Vaccine Revenue in 2022
Figure 22. North America Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. North America Human Bacterial Vaccine Market Share by Country (2024-2034)
Figure 24. United States Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. Canada Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Europe Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Europe Human Bacterial Vaccine Market Share by Country (2024-2034)
Figure 28. Germany Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. France Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. U.K. Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Italy Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Russia Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Nordic Countries Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Asia-Pacific Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Asia-Pacific Human Bacterial Vaccine Market Share by Region (2024-2034)
Figure 36. China Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Japan Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. South Korea Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Southeast Asia Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. India Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Australia Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Latin America Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Latin America Human Bacterial Vaccine Market Share by Country (2024-2034)
Figure 44. Mexico Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Brazil Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Middle East & Africa Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Human Bacterial Vaccine Market Share by Country (2024-2034)
Figure 48. Turkey Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 49. Saudi Arabia Human Bacterial Vaccine Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in Human Bacterial Vaccine Business (2024-2024)
Figure 51. Sanofi Revenue Growth Rate in Human Bacterial Vaccine Business (2024-2024)
Figure 52. GSK Revenue Growth Rate in Human Bacterial Vaccine Business (2024-2024)
Figure 53. Mitsubishi Tanabe Pharma Revenue Growth Rate in Human Bacterial Vaccine Business (2024-2024)
Figure 54. Pfizer Revenue Growth Rate in Human Bacterial Vaccine Business (2024-2024)
Figure 55. Bayer Revenue Growth Rate in Human Bacterial Vaccine Business (2024-2024)
Figure 56. Emergent BioSolutions Revenue Growth Rate in Human Bacterial Vaccine Business (2024-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed